30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 10:30 a.m. Wright Medical acquired IMASCAP, developer of the technology that drives BLUEPRINT™ 3D surgical planning software, for US $88.8MM in cash, stock and milestone payments.
  • Orthocell was granted a European Patent covering the manufacture of tendon regeneration cells used to form the Ortho-ATI® Autologous Tenocyte Implantation product.
  • 12:00 p.m. Bodycad entered into an exclusive agreement with OrthoGrow for distribution of its unicompartmental knee in the European Union.
Read More

Articles of Interest All Articles

FDA Finalizes Additive Manufacturing Guidance

FDA recently published its guidance on additive manufacturing technical considerations, outlining the Agency’s long-awaited position on use of the technology for medical devices.